We aim to describe PTCH-1 and MDM2 expression in ameloblastoma from Nigerian patients to characterize the possible direct or implied chemotherapeutic potential presented by PTCH-1 and p53 in this neoplasm. The gene discussed is PTCH1; the disease is ameloblastoma.